Agfa names leadership for combined businessesAgfa’s integration of Sterling Diagnostic Imaging has begun to move forward. The company has appointed its North American management team for the combined Sterling and Agfa businesses. Former
Agfas integration of Sterling Diagnostic Imaging has begun to move forward. The company has appointed its North American management team for the combined Sterling and Agfa businesses. Former Sterling employees are well represented.
Sterling COO Ernest Waaser has been named senior vice president of North America, replacing John Glass, who is now managing director of Agfas worldwide medical imaging business.
Sterling senior vice president for Americas Robert Pryor has been tapped as vice president of North American sales, handling field sales, national accounts, and the companys efforts in the U.S. militarys Digital Imaging Network-Picture Archiving and Communications Systems (DIN-PACS) project.
Agfa veteran Robert Cooke has been named vice president of Impax Solutions, continuing his previous responsibilities for product management, marketing, and professional services for the PACS and CR businesses. Michael Sullivan has been appointed vice president of customer support. He has handled similar responsibilities for Agfa.
Sterling executive director of worldwide marketing William Ward will head up marketing communications and strategy, while John Wilkens will lead the firms business development efforts. Wilkens had previously served as vice president of Sterlings Imaging Media Systems business.
Finally, Agfa has received a $5.6 million PACS and CR contract from Elmhurst Hospital Center in Elmhurst, NY. Agfa expects to complete installation at the 500-bed hospital in late September.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.